secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2021-09-16T23:59:59+00:00
Accession:  0001193125-21-275102
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kymera CSO Richard Chesworth to depart Oct 22; search underway
--------------------------------------------------------------

- Richard Chesworth steps down as Chief Scientific Officer effective October 22, 2021.
- Departure not related to any disagreements with company on operations, policies, or financial matters.
- Company has initiated a search for a new chief scientific officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312521275102/0001193125-21-275102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312521275102/d218603d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-275102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer